Phospholipase A2 expression in prostate cancer as a biomarker of good prognosis: A comprehensive study in patients with long follow-up.

Saulo da Cunha RecueroNayara I VianaSabrina T ReisKeith T MendesLeda L TalibWagner F GattazVanessa R GuimarãesIran A SilvaRuan C P PimentaJuliana A CamargoWillian C NahasMiguel SrougiKatia Ramos Moreira Leite

Published in: Urologia (2024)

This is the first study exploring comprehensively the expression levels of PLA2 in PCa, showing that the higher expression of some PLA2 should be used as biomarkers of good prognosis and longer disease-free survival.

Keyphrases

poor prognosis
prostate cancer
free survival
binding protein
long non coding rna
radical prostatectomy